CERT logo

CERT

Certara Inc.

$5.45
-$0.17(-3.02%)
46
Overall
60
Value
27
Tech
52
Quality
How is this score calculated?
Market Cap
$861.69M
Volume
2.19M
52W Range
$5.24 - $15.38
Target Price
$9.08

Company Overview

Mkt Cap$861.69MPrice$5.45
Volume2.19MChange-3.02%
P/E Ratio-71.5Open$5.81
Revenue$385.1MPrev Close$5.62
Net Income$-12.1M52W Range$5.24 - $15.38
Div YieldN/ATarget$9.08
Overall46Value60
Quality52Technical27

No chart data available

About Certara Inc.

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Sector: Technology
Industry: Software Publishers

Latest News

Cerrado Gold Posts Record 2025 EBITDA as Minera Don Nicolas Ramps Up Underground Output

The latest update is out from Cerrado Gold ( ($TSE:CERT) ). Cerrado Gold reported 2025 annual production of 50,238 gold equivalent ounces at its Mi...

TipRanks Canadian Auto-Generated Newsdesk7 days ago

Certara Announces Upcoming Board and Audit Committee Change

TipRanks Auto-Generated Newsdesk8 days ago
ABCD
1SymbolPriceChangeVol
2CERT$5.45-3.0%2.19M
3
4
5
6

Get Certara Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.